Home
News
Create
Screeners
Insights
Everest Organics
418.
90
+2.50
(+0.60%)
Market Cap
₹- Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.60%
1M
+8.35%
6M
-0.10%
1Y
+188.20%
5Y
+66.13%
View Company Insights
Latest news about Everest Organics
Everest Organics Seeks Shareholder Approval for Board Restructuring Through Postal Ballot
Nov 15, 2025
Everest Organics Limited has issued a postal ballot notice seeking shareholder approval for three special resolutions to restructure its board. The proposals include appointing Mr. Venkata Satya Subbarao Pachigolla as Whole-Time Director, redesignating Mr. Kirankumar Rampally from Non-Executive Non-Independent to Non-Executive Independent Director, and changing Mr. Prasad Venkata Satya Sundara Srikakolapu's designation from Non-Executive Independent to Non-Executive Non-Independent Director. The e-voting period is set from November 17 to December 16, 2025, with results to be declared by December 18, 2025.
Everest Organics Reports Q2 FY2026 Profit, Announces Board Changes Amid Operational Challenges
Nov 13, 2025
Everest Organics Board Approves Key Director Re-appointments and New Company Secretary
Aug 05, 2025
Everest Organics Reports Profit Turnaround, Approves Key Management Reappointments
Aug 05, 2025
Everest Organics Secures Korean Drug Master File Approval for Rabeprazole Sodium API
Feb 18, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation